Latest Rodenticides Stories
A new study by researchers at the Intermountain Medical Center Heart Institute in Salt Lake City has found that atrial fibrillation patients who are on blood thinning medications are at higher risk of developing dementia if their doses are not in the optimal recommended range.
Recently Released ACC/AHA Practice Guidelines Reinforce Unmet Need MENLO PARK, Calif., April 29, 2014 /PRNewswire/ -- Armetheon, Inc., today announced that it has reached agreement
Lead Investigator Discusses Findings With AJMC, Says Results Show Importance of Self-Testing Plainsboro, NJ (PRWEB) March 26, 2014 The American Journal
DUBLIN, March 13, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/3d7f2f/aluminium) have announced the addition of the "Aluminium
Although some research has suggested that the use of the anticoagulant warfarin for atrial fibrillation among patients with chronic kidney disease would increase the risk of death or stroke, a study that included more than 24,000 patients found a lower l-year risk of the combined outcomes of death, heart attack or stroke without a higher risk of bleeding.
The Quest Diagnostics Health Trends(TM) study of 2.7 million test results is the largest to examine warfarin treatment in patients with atrial fibrillation (Afib) treated in primary care and other
Patients with atrial fibrillation – an irregular and often abnormally fast heartbeat – have nearly double the risk of suffering a stroke in the first 30 days after starting to take the anti-clotting drug warfarin compared to non-users.